Patent details
EP1827374 Title: INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
Basic Information
- Publication number:
- EP1827374
- PCT Application Number:
- PCT/US/2005/041470
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP058517012
- PCT Publication Number:
- WO/2006/055603
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
- French Title of Invention:
- FORMULATIONS INJECTABLES DE NANOPARTICULES D'OLANZAPINE
- German Title of Invention:
- INJIZIERBARE OLANZAPIN-FORMULIERUNGEN IN NANOTEILCHENFORM
- SPC Number:
Dates
- Filing date:
- 16/11/2005
- Grant date:
- 05/11/2014
- EP Publication Date:
- 05/11/2014
- PCT Publication Date:
- 26/05/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/09/2007
- EP B1 Publication Date:
- 05/11/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 16/11/2014
- Expiration date:
- 16/11/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/11/2005
- Name:
- Alkermes Pharma Ireland Limited
- Address:
- Connaught House 1 Burlington Road, Dublin 4, Ireland (IE)
Inventor
1
- Name:
- JENKINS Scott
- Address:
- United States (US)
2
- Name:
- LIVERSIDGE Gary
- Address:
- United States (US)
3
- Name:
- LIVERSIDGE Elaine
- Address:
- United States (US)
Priority
- Priority Number:
- 628748 P
- Priority Date:
- 16/11/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/14;
Publication
European Patent Bulletin
- Issue number:
- 201807
- Publication date:
- 14/02/2018
- Description:
- Opposition rejected; Patent maintained as granted
| Filing date | Document type | Number of pages |
|---|